Clinical trials
Completed Leukemia, Myelomonocytic, Chronic trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 5 |
| Wake Forest University Health Sciences | 2 |
| Asan Medical Center | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| City of Hope Medical Center | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Martin, Paul | 1 |
| OHSU Knight Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 20 |
| Burkitt Lymphoma | 16 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 16 |
| Leukemia, Myeloid, Acute | 16 |
| Lymphoma, Large B-Cell, Diffuse | 16 |
| Multiple Myeloma | 16 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Congenital Abnormalities | 15 |
| Hodgkin Disease | 15 |
| Leukemia, Myeloid, Chronic-Phase | 15 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.